The IN-TDDR research group specializes in innovative nanobiotechnology and translational drug delivery. It develops smart, safe, and sustainable pharmaceutical systems, bridging laboratory research with clinical, industrial, and environmental applications. The group addresses global challenges such as cancer therapy, antimicrobial resistance, and sustainable materials.
Vortioxetine-protein complex encapsulated in bio-adhesive polymeric nano micelles (Patent No. SA 23007 B1), Saudi Authority for Intellectual Property, 2026. Retrieved from https://www.saip.gov.sa
Recent High-Impact (2025–2026):
Status: Ongoing & completed
